ArticleFunctional & integrative genomics2024
CRISPR-Cas9-mediated deletion enhancer of MECOM play a tumor suppressor role in ovarian cancer.
Yujie Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it